Skip to main content
logo
Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
16.76
-0.29 (-1.70%)
Nov 11, 2026, 4:08 PM HKT

Sinopharm Group Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
37,83348,79654,31363,80955,22243,529
Short-Term Investments
-2,7583,1723,3303,1992,812
Trading Asset Securities
0.090.130.160.550.511.75
Cash & Short-Term Investments
37,83351,55457,48667,13958,42146,353
Cash Growth
-2.43%-10.32%-14.38%14.92%26.04%-12.29%
Accounts Receivable
231,466206,652201,479185,790171,204172,576
Other Receivables
18,2564,9385,2484,0073,7033,698
Receivables
249,721211,589206,727189,797174,908176,273
Inventory
67,83563,34162,35360,02860,92651,500
Restricted Cash
-1,3541,3281,8501,488-
Other Current Assets
8,30018,95719,55418,02223,66516,796
Total Current Assets
363,689346,796347,448336,835319,406290,922
Property, Plant & Equipment
14,61118,22919,63219,89819,64719,408
Long-Term Investments
11,21511,31010,89410,5519,8409,184
Goodwill
5,7355,7846,2527,1867,1567,199
Other Intangible Assets
3,6392,2492,4732,8302,9413,116
Long-Term Accounts Receivable
-896.71,156793.921,123874.58
Long-Term Deferred Tax Assets
3,0152,8492,4081,9641,9801,787
Long-Term Deferred Charges
88.32142.29224.01180.0274.4476.61
Other Long-Term Assets
5,8812,1062,3443,1582,6072,845
Total Assets
407,873390,361392,831383,395364,775335,412

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
158,128150,248151,109146,632137,085128,431
Accrued Expenses
1,7057,5478,1238,8329,5718,354
Current Portion of Long-Term Debt
-63,32162,72954,73052,99755,152
Current Portion of Leases
-1,4991,7611,7971,6361,548
Current Income Taxes Payable
2,1321,4121,4471,7751,7031,614
Current Unearned Revenue
6,5775,9846,8296,39910,3966,086
Other Current Liabilities
23,31616,71418,37721,32621,57418,122
Total Current Liabilities
258,683246,726250,376241,491234,963219,307
Long-Term Debt
4,5713,6458,63713,83411,7508,419
Long-Term Leases
2,3182,4953,2593,4213,2073,250
Long-Term Unearned Revenue
364.21417.32413.86448.24493.85462.74
Pension & Post-Retirement Benefits
-364.9412.88366.51380.71387.7
Long-Term Deferred Tax Liabilities
532.64565.22638.75788.38936.741,023
Other Long-Term Liabilities
2,1331,9882,4062,7272,9752,910
Total Liabilities
268,602256,201266,144263,076254,706235,758

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
3,1213,1213,1213,1213,1213,121
Additional Paid-In Capital
20,47924,64124,64124,64124,64124,641
Retained Earnings
63,63560,56555,53251,19744,70138,516
Treasury Stock
-3.84-3.84-3.84-3.84-3.84-3.84
Comprehensive Income & Other
8.32-4,370-4,407-4,373-4,391-4,388
Total Common Equity
87,23983,95378,88474,58268,06961,886
Minority Interest
52,03150,20647,80445,73742,00137,768
Shareholders' Equity
139,271134,160126,687120,319110,06999,654
Total Liabilities & Equity
407,873390,361392,831383,395364,775335,412

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
73,71370,96076,38673,78269,59068,368
Net Cash (Debt)
-35,881-19,407-18,900-6,643-11,169-22,016
Net Cash Growth
------
Net Cash Per Share
-11.49-6.22-6.06-2.13-3.58-7.05
Filing Date Shares Outstanding
3,1213,1213,1213,1213,1213,121
Total Common Shares Outstanding
3,1213,1213,1213,1213,1213,121
Working Capital
105,005100,07097,07295,34484,44371,616
Book Value Per Share
27.9626.9025.2823.9021.8119.83
Tangible Book Value
77,86575,92170,15964,56657,97251,571
Tangible Book Value Per Share
24.9524.3322.4820.6918.5816.53
Buildings
-14,23413,75212,99712,90712,127
Machinery
-11,19810,72810,0999,1698,412
Construction In Progress
-842.34739.81505.47800.05718.53